Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • noatz
    Junior Member
    • Feb 2012
    • 1

    #1

    Cuffdiff 2.1.1 normalization

    Hi,
    I used cuffdiff 2.1.1 with the default geometric normalization, which should not consider the transcripts' length but only the geometric mean of number of counts per sample (as DESeq does).
    If this is so, I don't understand the meaning of 2 other optional parameters:

    --no-effective-length-correction: "Cufflinks will not employ its "effective" length normalization to transcript FPKM"
    and
    --no-length-correction: "Cufflinks will not normalize fragment counts by transcript length at all (??). Use this option when fragment count is independent of the size of the features being quantified (e.g. for small RNA libraries, where no fragmentation takes place, or 3 prime end sequencing, where sampled RNA fragments are all essentially the same length). Experimental option, use with caution".

    Can anyone tell the difference between these 2 options, and why are they needed if the geometric mean normalization does not consider the length anyway?
    Thanks
    Noa

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Working...